On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...

Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

Sequentially, revenue from operations grew by 2.9 per cent, whereas profit after tax (PAT) fell by 4.5 per cent ...

“AI-based software significantly improved detection of ultrasounds that were suspicious for congenital heart defects not only ...